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Abstract: In vitro studies have shown that amnion-produced growth factors participated in angiogenesis, re-epi-
thelialization, and immunomodulation. The aim of our study was to investigate the growth factors and receptors 
produced by human amnion tissue and amniotic cells. Human amnions (hAM) were isolated, and amnion circles 
were dissected for in vitro analysis. Some amnion fragments were digested by the use of different methods to 
obtain two cell fractions, which were analysed for mesenchymal and epithelial cell markers. Amniotic circles and 
human amniotic cell fractions were cultured in a protein-free medium. Proteins secreted into the culture medium 
were analysed with a human growth factor antibody array. Conditioned culture media were added to human 
umbilical vein epithelial cells (HUVECs) to test for stimulation of migration (scratch test) and proliferation 
(Ki67 expression). Fraction 1 cells expressed both cytokeratin and mesenchymal cell markers which indicated 
that it was composed of a mixture of human amnion epithelial cells (hAECs) and mesenchymal stromal cells 
(hAMSCs). Fraction 2 cells mainly expressed cytokeratin and, therefore, were designed as hAECs. Secretion 
of proteins by the cultured cells increased with time. The hAM cultures secreted EGF-R, IGF, and IGFBP-2, 
-3 and -6; Cell Fraction 1 secreted NT-4, whereas Cell Fraction 2 secreted G-CSF, M-CSF, and PDGF. Con-
ditioned media of hAM cultures stimulated HUVECs migration. We have showed for the first time that human 
amnions and amniotic cells secreted IGFBP-6, MCSF-R, PDGF-AB, FGF-6, IGFBP-4, NT-4, and VEGF-R3. 
We found that Cell Fraction 1, Cell Fraction 2, and the whole amnion secreted different proteins, possibly due to 
different proportions of amnion-derived cells and different cell-cell interactions. The hAM cell factors remained 
functional in vitro and induced intensified migration of HUVECs. The growth factors and receptors found in 
amnion or amniotic cell media might be used for regenerative medicine. (Folia Histochemica et Cytobiologica 
2014, Vol. 52, No. 3, 163–170)
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Introduction
Human foetal membranes, the amnion and chorion, 
enclose the foetus in the amniotic cavity. The inner 
surface of the human amnion (hAM), which faces the 
amniotic cavity, comprises human amniotic epithelial 
cells (hAECs). The outer layer of the hAM comprises 
human amniotic mesenchymal stromal cells (hMSCs), 
which are surrounded by an intercellular matrix. One 
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of the functions of amniotic cells is the release of 
growth factors and cytokines, which regulate different 
processes during the development of the embryo [1]. 
During foetal development, an important regu-
latory factor is vascular endothelial growth factor 
(VEGF). VEGF increases the permeability of the 
human amnion [2]. During pregnancy, amniotic fluid 
is constantly exchanged and deregulation of amniotic 
fluid volume may result in polyhydramnios or oligohy-
dramnios, which are associated with preterm birth and 
perinatal morbidity or mortality [2].
In vitro studies have shown that amnion-produced 
growth factors participated in angiogenesis, re-epithe-
lialization, and immunomodulation [3]. Some factors 
stimulate cell differentiation and proliferation, like 
macrophage colony-stimulating factor (M-CSF), 
which was detected in cultures of human amniocy - 
tes [4]. Other factors, like IGF-2, were found on 
mRNA level in human amniotic epithelial cells, where 
they may promote proliferation [5]. 
This study aimed to determine the capacity of hu-
man amnions (hAMs) and isolated human amniotic 
cells (hAMCs) to produce growth factors and re-
ceptors. Cell fractions were further isolated to test 
whether cells in different fractions showed differences 
in the production of growth factors. We assumed that 
the relative proportions of the isolated cell fractions 
may affect various amounts of growth factors found 
to be released by amniotic cells in vitro. 
Material and methods
Experiments were performed with the approval of the Bio-
ethics Commission at The Medical Centre of Postgraduate 
Education (accepted on December 5, 2012). Seven full-term 
human placentas were obtained from healthy women after 
obtaining informed written consent. We analysed seven 
amniotic samples; four samples were used for the human 
growth factor antibody array and three were used for cyto-
metric analyses. 
Isolation of amnions and amniotic cells. Cell fractions 
were isolated according to a protocol described previously, 
by Soncini et al. [6], with minor modifications. Amnions 
were obtained from the Clinical Department of Midwifery 
and Gynaecology, Bielanski Hospital, Warsaw, Poland. 
Amnions were mechanically separated from placentas 
and cut into pieces. These fragments were washed twice 
in phosphate-buffered saline (PBS, pH = 7.4, Sigma-Al-
drich, St. Louis, MO, USA) and incubated for 30 min in 
PBS with penicillin (7.5 × 105 IU/mL, Polfa Tarchomin, 
Poland), streptomycin (0.25 g/mL, Polfa), and nystatin 
(2.5 mg/mL, Sigma-Aldrich). After another wash with PBS, 
the amniotic fragments were cut with a Biopsy Punch (Miltex, 
York, PA, USA) to obtain 5-mm wide circles of tissue, which 
were placed in a 4 wells in 48-well culture plate (ten circles 
per well). The remainder of the amniotic fragments (on av-
erage, 1.84 g of tissue) was divided in half, and each portion 
was dissociated enzymatically. The first portion of amniotic 
fragments was incubated in a mixture of 2.4 U/mL dispase 
(Sigma-Aldrich) and 20 µg/mL deoxyribonuclease I (Sig-
ma-Aldrich) in PBS for 7 min at 37°C. Then, the mixture was 
incubated with type I clostridial collagenase (0.75 mg/mL, 
Sigma-Aldrich) in PBS for 3 h at 37°C. Next, the cells were 
transferred to a new test tube with PBS and 2 mM EDTA, 
and centrifuged for 5 min at 230 g. Then, the pellet was 
washed with physiological NaCl solution (PS-NaCl), and fil-
tered through a sterile nylon Cell Strainer (pore size 100 µm; 
BD, Franklin Lake, NJ, USA). The resulting cell suspension 
was designated Cell Fraction 1. The remaining portion of 
amniotic membrane fragments was incubated for 2–5 min 
in 0.25% trypsin and EDTA (Invitrogen, Grand Island, NY, 
USA) at 37°C. Then, cells were suspended in 2.5% human 
albumin in PBS (SIS Biomed, Warsaw, Poland) and centri-
fuged for 5 min at 230 g. The cell pellet was washed in PS-NaCl 
and filtered through a Cell Strainer (pore size 100 µm, 
BD). The resulting cells were designated Cell Fraction 2.
Cultures of amniotic circles and isolated cell fractions. 
Amniotic circles (ten per well) and isolated cell fractions 
were separately incubated and cultured in a protein-free 
RPMI 1640 medium (Gibco, Grand Island, NY, USA) 
with the standard addition of penicillin/streptomycin in 
a humidified 5% CO2 atmosphere at 37°C. Cell Fraction 1 
comprised an average of 0.45 × 105 cells suspended in 0.6 mL 
per well; Cell Fraction 2 comprised an average of 0.3 × 106 
cells suspended in 0.6 mL per well. Different cell fractions 
and tissue cultures were incubated for 3, 6, 24 or 48 hours. 
The 3 hours incubation time point was treated as baseline, 
and incubation for 48 hours was the end point. We did not 
test longer cell cultures to avoid changes in the original cell 
properties. After the indicated culture times, the conditioned 
culture media were collected and centrifuged for 10 min at 
1000 g; the culture media were then aliquoted and frozen 
at –80°C until further analysis.
Isolation of human umbilical vein endothelial cells (HU-
VEC). Umbilical cords obtained from placenta donors 
were washed with PBS and then filled with Hanks buffer 
(Sigma-Aldrich) to remove erythrocytes. Next, umbilical 
veins were filled with dispase (0.96 mg/mL, Gibco) and in-
cubated for 15 min at 37°C in a heated bath. The liberated 
cells were removed and centrifuged. Then, the umbilical 
veins were washed with Medium 199 (Sigma-Aldrich) to re-
trieve cells, and the cell suspension was centrifuged at 230 g. 
The cells were pooled and cultured for 4–5 h in Medium 
199, and, finally, the culture medium was changed to remove 
non-adherent cells.
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Cytometric analysis of amniotic and endothelial cells. Cell 
Fractions 1 and 2 were tested for the presence of mesenchy-
mal cell surface markers by probing with specific antibodies 
conjugated to allophycocyanin (APC), phycoerythrin (PE) 
or fluorescein isothiocyanate (FITC), including: anti-CD90 
APC (clone 5E10, BD); anti-CD73 PE (clone TY/23, 
BD); anti-CD105 PE (clone 266, BD), and antibodies 
against epithelial cytoplasmatic markers, anti-cytokeratins 
4/5/6/8/10/13/18 FITC (clone C11, AbD Serotec, Kidiling-
ton, UK). Additionally, Cell Fraction 1 was probed with 
anti-CD45 FITC (clone HI30, BD) and anti-CD34 PE (clone 
581, BD). Isotype controls were: PE isotype control (clone 
MOPC-21, BD); FITC isotype control (clone MOPC-21, 
BD); and APC isotype control (clone MOPC-21, BD). 
HUVECs were probed with an antibody against the Ki67 
proliferation marker, anti-Ki67 PE (clone B56, BD) and 
with the PE isotype control (clone B56, BD).
Labelled cells were analysed by flow cytometry with the 
FACSCanto II cytometer (BD) and FacsDiva software (BD).
Cytokine antibody array. We analysed the proteins in the 
conditioned culture media with a human growth factor an-
tibody array (RayBiotech, Atlanta, GA, USA). The array 
can detect 41 growth factors and receptors (Table 1), and 
the assay was performed according to the manufacturers’ 
protocol. Briefly, the analytic membrane was blocked in 
Blocking Buffer for 30 min; then, it was incubated with the 
sample at 4°C overnight, washed five times in buffer, and 
incubated in the biotin-conjugated antibody solution for 
90 min. The membrane was then washed five times and 
incubated in horseradish peroxidase-(HRP)-conjugated 
streptavidin for 90 min, followed by another wash procedure. 
Finally, the array was incubated in a mixture of Detection 
Buffers for 2 min, and visualised with a chemiluminescence 
imaging system (UVP camera, Gel Doc — Imaging System, 
BioRad, Hercules, CA, USA). 
Image-densitometry analyses for the cytokine antibody 
array were performed with ImageJ software (NIH, Bethesda, 
MD, USA) and the Protein Array Analyser plug-in. The 
intensity of each spot was quantified, and relative expression 
levels between proteins were calculated. The spot intensity 
was quantified in arbitrary densitometry units; the positive 
and negative controls were used to determine relative values. 
All values were multiplied by 100.
Scratch test. Isolated HUVECs were placed in a 12-well dish 
and cultured for three days in Medium 199 (Sigma-Aldrich) 
with 20% foetal bovine serum (Gibco), human endothelial 
cell growth factor supplement (1 µg/mL Millipore, Darm-
stadt, Germany), HEPES (0.2 µg/mL Sigma-Aldrich), and 
the standard concentrations of antibiotics. After cell cultures 
achieved confluence, a 3-mm scratch was made on the bot-
tom of each well to create a clear, cell-free line. Then, after 
24 h of culture, hAM-conditioned medium was collected, 
and aliquots were added (10% v/v) to the six HUVEC wells, 
and HUVECs were cultured for another three days. To the 
six other HUVEC wells (controls) 10% (v/v) RPMI 1640 
protein-free medium was added. At 24 h after making the 
scratch, cell growth into the clear area was observed with 
an inverted microscope (IX 71, Olympus, Tokyo, Japan), 
and the width of the scratch was measured with cellSence 
Dimension software (Olympus).
Statistical analysis. The growth factor antibody array re-
sults were expressed as the medians and interquartile range 
(25–75%). Groups were compared with the Mann-Whitney 
test. Statistical significance was set at p < 0.05.
Results
Characteristics of amniotic cells
In Cell Fraction 1, most cells stained positively for 
the following mesenchymal cell markers (median 
percentages): CD73 (86%), CD90 (19.3%), and 
CD105 (2.2%). Only 8.6% of Fraction 1 cells expres-
Table 1. Growth factors, their receptors and other proteins measured by the protein array
Growth factor families Tested members
Epidermal and fibroblasts growth factors *HB-EGF *EGF-2 EGF-R *bFGF *FGF-4 *FGF-6 *FGF-7
Neural and glial growth factors *bNGF *GDNF *NT-3 NT-4
Angiogenic growth factors *VEGF *VEGF-D *VEGF-R2 *VEGF-R3 PLGF
Haematopoietic growth factors G-CSF *GM-CSF M-CSF M-CSF-R *SCF *SCF-R
Insulin-like growth factors *IGF-1 IGF-2 *IGF-ISR *IGFBP-1 IGFBP-2 IGFBP-3 *IGFBP-4 IGFBP-6
Platelet derived growth factors *PDGF-AA PDGF-AB *PDGF-BB *PDGFRa *PDGFRb
Transforming growth factors *TGF-a *TGF-b *TGF-b2 *TGF-b3
Other proteins *HGF *AR
Asterisk (*) denote proteins found in the culture media of human amniotic membranes, Cell Fraction 1 and Cell Fraction 2, which concentrations 
did not change during the time of culture duration. Assays were performed as described in Methods
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sed the epithelial cell markers, i.e. cytokeratins 
4/5/6/8/10/13/18. 
In Cell Fraction 2, most cells (98.4%) expressed the 
epithelial cell markers, cytokeratins 4/5/6/8/10/13/18, 
and only few cells expressed mesenchymal cell mar-
kers: CD73, CD90 and CD105 (Table 2). 
We calculated that the intact amniotic membrane 
circles comprised of equal hAMSCs and hAECs cell 
markers (Table 3).
Presence of growth factors and receptors  
in conditioned media
The use of cytokine antibody array revealed some 
individual differences among the amnions of different 
women. However, all tested proteins were present in 
the supernatants (Table 1). In this work, we focused 
only on statistically significant changes over time in the 
levels of growth factors and their receptors (Table 4). 
From both the intact human amnion circles and the 
isolated amnion cells (Fractions 1 and 2), we found 
some factors released to the culture medium that had 
not been reported previously, including IGFBP-6, 
M-CSF receptor (M-CSF-R), heterodimer of platelet 
derived growth factors AB (PDGF-AB), fibroblast 
growth factor-6 (FGF-6), IGFBP-4, neurotrophin-4 
(NT-4), and VEGF receptor-3 (VEGF-R3), as shown 
in Table 5. 
Presence of growth factors and receptors in human 
amnion culture media 
Relative changes in the secretion of growth factors 
and receptors were measured over time, starting 
at 3 h of culture. In the course of culturing hAMs, 
we observed in culture medium increasing levels of 
IGF-2, IGFBPs-2, -3, and -6, and the EGF receptor 
(EGF-R) (Table 4).
The relative concentration of IGFBP-2 increased by 
about 4-fold from 3 to 48 h. However, IGFBP-3 sho-
wed a much greater concentration increase; between 
3 and 48 h, IGFBP-3 level increased up to 41-fold, and 
between 6 and 48 h — 13-fold. The relative IGFBP-6 
concentration was augmented nearly 6-fold between 
6 and 48 h. The relative concentration of IGF-2 in-
creased about 1.5-fold between 6 and 48 h (Table 4).
The EGF-R concentration was about 3-fold higher 
at 48 h compared to the value at 24 h. These observa-
tions suggested that hAM cultures continuously pro-
duced these factors within the tested period of time.
Table 2. Expression of mesenchymal and epithelial cell markers in the fractions of cells isolated from human amnions
Cells Marker Median (%) P25–P75 (%)
Cell Fraction 1
CD73+
CD90+
CK 4/5/6/8/10/13/18+
CD105+
86.0
19.3
8.6
2.2
50.9–91.6
16.3–23.7
6.6–53.7
1.5–47.3
Cell Fraction 2
CD73+
CD90+
CK 4/5/6/8/10/13/18+
CD105+
CD45+
CD34+
1.5
11.8
98.4
4.1
0.2
0.0
1.5–5.4
10.3–26.8
97.1–99.0
2.6–8.8
0.1–0.8
0.0
Data are expressed in percentages and were obtained from 3 independent experiments. Cell Fraction 1 — human amniotic cells isolated with 
dispase and collagenase; Cell Fraction 2 — human amniotic cells isolated with trypsin; CK — cytokeratin
Table 3. Proportion of cells in human amniotic membranes
Mesenchymal cells (CD73+) Epithelial cells  
CK 4/5/6/8/10/13/18+
Total in each fraction
Cell Fraction 1 0.86 0.09 0.94
Cell Fraction 2 0.02 0.98 1.00
Total of both fractions 0.88 1.07 1.94
Calculated proportions of cells in hAM 0.45 0.55 –
Description as for Figure 1 and Table 2. Data were obtained from 3 independent experiments
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In some cases, growth factors (e.g., EGF-R, IGF-2, 
and IGFBP-6) exhibited lower concentrations in the 
conditioned media at 6 h than at 3 h, however, these 
differences were not statistically significant (Table 4).
Cell Fraction 2 culture medium
Cell Fraction 2, which contained mainly epithelial cells, 
expressed haematopoietic growth factors, including 
granulocyte colony-stimulating factor (G-CSF), M-CSF, 
PDGF, and the angiogenesis regulator, PLGF (Table 4). 
The G-CSF concentration level doubled between 
3 and 48 h. The relative M-CSF concentration incre-
ased 1.5-fold between 6 and 24 h; the level of M-CSF 
receptors (M-CSF-R) increased relatively little. The 
heterodimeric PDGF-AB level doubled between 
3 and 24 h. The level of PLGF increased 1.6-fold be-
tween 24 and 48 h. The release of these factors into 
the culture medium suggested that factors released 
by the amniotic epithelial cell fraction may regulate 
locally blood cell differentiation and vasculogenesis. 
Cell Fraction 1 culture medium
Cell fraction 1 contained mostly mesenchymal cells. 
Among all 41 tested proteins, only the relative con-
Table 5. Novel proteins detected in the conditioned culture 
media of human amniotic membranes and fractions of 
isolated amniotic cells
Growth factor Cells
IGFBP-6 hAM
FGF-6 Cell Fraction 1
IGFBP-4 Cell Fraction 1
NT-4 Cell Fraction 1
VEGF-R3 Cell Fraction 1
M-CSF-R Cell Fraction 2
PDGF-AB Cell Fraction 2
Description as for Table 2, n = 4. These proteins were not detected in 
other studies (see Discussion)
Table 4. Concentrations of proteins in conditioned media of human amnions and isolated amniotic cell cultures
Duration of cultures
3 hours 6 hours 24 hours 48 hours
Whole human amniotic membranes
EGF-R 0.10 
(0.00–0.30)
0.00
(0.00–0.11)
0.41# 
(0.31–0.71)
1.19#
(0.86–1.53)
IGF-2 1.7 
(0.50–3.90)
1.38
(0.95–1.70)
1.82
(1.17–3.38)
2.30#
(1.92–2.59)
IGFBP-2 1.75 
(0.51–3.89) 
3.71*
(2.03–5.28)
4.73
(2.74–6.73)
7.26*
(5.60–7.66)
IGFBP-3 0.05 
(0.00–0.26) 
0.16*
(0.00–5.00)
1.38
(0.53–1.93)
2.03*
(1.20–2.56)
IGFBP-6 0.30 
(0.10–0.80)
0.27
(0.06–0.60)
0.90
(0.46–1.36)
1.54*
(1.05–2.05)
Cell Fraction 1
NT-4 0.20
(0.20–0.30)
0.14
(0.01–0.28)
0.36#
(0.31–0.39)
0.19
(0.04–0.39)
Cell Fraction 2
M-CSF 0.60 
 (0.50–0.70)
0.66
(0.57–0.79)
1.11#
(0.92–1.25)
0.80
(0.47–0.99)
M-CSF-R 0.60
(0.31–0.74)
0.60
(0.45–0.78)
0.78* 
(0.76–1.01)
0.60
(0.41–0.82)
PDGF-AB 0.13
 (0.06–0.15)
0.25
(0.15–0.29)
0.31*
(0.29–0.34)
0.30*
(0.24–0.36)
PLGF 0.60
(0.40–1.10)
0.40
(0.34–0.55)
0.26
(0.24–0.32)
0.41$
(0.38–0.45)
G-CSF 0.26
 (0.18–0.44)
0.44
(0.27–0.95)
0.56
(0.40–0.83)
0.58*
(0.47–0.86)
Human amniotic membranes and isolated Cell Fraction 1 and 2 cells were cultured for 3, 6, 24 or 48 hours, and culture media were collected and 
processed as described in Methods. Data represent median values and P25–P75 (n = 4). *, #, $Significantly different results versus 3 h, 6 h or 24 h 
values, respectively, p < 0.05
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centration of NT-4 increased statistically significantly 
during the study time period. Between 6 and 24 h, 
NT-4 increased by 2.6-fold. Because the amnion has 
no neural supply, this finding suggested that NT-4 
played an important local role in the function of the 
amnion epithelium, possibly related to apoptosis.
Factors released by hAM cells affect function  
of cultured HUVECs 
When 24-h conditioned hAM medium was added at 
10% to HUVEC cultures, the growth of HUVECs 
over the scratch regions was, on average, 3 times 
greater than in control wells (cell growth covered 
893 µm vs. 289 µm, respectively; p < 0.05; Figure 1). 
To support the finding that conditioned medium 
induced more intensive cell growth, we tested the 
cellular expression of Ki67, a proliferation marker. 
The HUVEC cultures that received 24-h conditioned 
hAM culture medium contained an average of 1.6- 
-fold more Ki67-positive cells than control cultures 
(8% vs. 5%, respectively), however, the differences 
were not statistically significant. Altogether, these 
results suggested that the conditioned hAM culture 
medium contained factors that increased the mobility 
of HUVEC cells. 
Discussion
Several previous studies reported that amniotic mem-
branes secreted interleukins [1, 3, 7–11], however, the 
secretion of growth factors was less characterized. 
Therefore, we measured 41 different growth factors 
and receptors that were known to be present in other 
tissues. Some of the tested regulatory proteins were 
released in Cell Fraction 1 and 2 cultures, others were 
only produced by hAM. In general, we observed rela-
tive increases in the concentration of growth factors 
in the culture medium over time. 
The original data, reported for the first time in this 
paper, was the finding that cultured human amnion 
secreted: FGF-6, NT-4, VEGF-R3, M-SCF-R, 
IGFBP-4, IGFBP-6, and PDGF-AB. The function of 
these growth factors in amnion is unknown. However, 
we hypothesize that their presence may depend on 
stress or experimental conditions, due to the fact that 
these growth factors are often released as a response 
to injury. Some of these factors may have effects 
within regenerating damaged tissue. For example, 
knock-out mice FGF-6–/– after skeletal muscle injury 
revealed fibrosis and myotube degeneration demon-
strating that FGF-6 seems to be component of the 
muscle regenerative machinery [12]. Experiment 
on NT4/5 knock-out mice revealed the role of NT-4 
in regeneration of axons in peripheral nerves [13]. 
Disconnection of lymph vessels in adult mice sugge-
sted activation of VEGF receptor 3 in the following 
reconnection of the collecting lymph vessels in the 
animals [14]. The in vitro study on human periodon-
tal ligament fibroblasts showed that PDGF-AB had 
mitogenic effect on the cells [15]. 
Several factors were described previously as 
amnion products; e.g., EGF-R was expressed in rat 
foetal membranes on days 18–22 of gestation [16] and 
human amniotic fluid was shown to contain 0.745 ± 
0.0056 pg/mL of epithelial growth factor (EGF) [17]. 
It was suggested that EGF could modulate the onset 
of parturition since EGF levels in human amniotic 
fluid increase steadily from 30 to 40 weeks of gesta-
tion [17], thus, EGF-R secreted by human amnions 
may have a regulatory function. We speculated that 
the release of EGF-R near the amnion surface may 
protect amnion epithelial cells against EGF activity. 
Moreover, it was reported that increased and susta-
ined levels of EGF-R and PDGF-R proteins acce-
lerated wound healing [18]; thus, we reasoned that 
EGF-R may have an additional function of protecting 
the amnion from delivery stress.
Figure 1. Scratch test of human umbilical cord vessel epi-
thelium cells. HUVEC cells were incubated with the hAM 
24 h culture medium as described in Methods. Y axis: dis-
tance covered by HUVEC cells. Data show median values 
and P25 (HUVEC P25 = 796 µm; HUVEC + hAM 24 h  
culture medium P25 = 145 µm) of the distance covered by 
the cells from the edge of the scratch. (n = 6; p < 0.05). 
Abbreviations: hAM — human amniotic membrane; HU-
VEC — human umbilical cord vessel epithelium cells
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Generally, our data stress the role of IGF and IGF-
-BPs secreted by amnion during human development. 
Our data on the expression of IGFBP-3 protein in 
human amniotic membrane tissue confirmed pre-
vious studies based on mRNA assays [19], however, 
some of the earlier observations were negative [20]. 
Our observation that the concentration of IGFBP-6 
increased over the duration of culture may suggest a 
functional regulatory role for the concomitant rise 
of IGF-2 levels, because IGFBP-6 has a high affinity 
for IGF-2 [21]. Also, IGFBP-3 has high affinity for 
IGF-2 [22–25] which may explain increase of its levels 
in culture medium during the course of the study. In 
general, proteins of the IGF family have a profound 
impact on embryo and placenta development [5, 19, 
26]. It was observed in a mouse model that placental 
weight correlated with foetal weight, and these pa-
rameters were correlated with cord blood levels of 
IGF-1 and -2 [5]. Moreover, IGF-1 and IGF-2 levels 
were also significantly lower in umbilical cord blood 
sera of foetuses with growth retardation compared to 
normal foetuses [5]. In the mouse model, disruption 
of one of the IGF-2 alleles caused death of about 
60% of mice [5]. 
Relative proportions of cells may influence 
the amount of factors released by amniotic cells. 
In accord with general knowledge, we found that 
the amniotic membrane comprised mainly two 
types of cells, mesenchymal and epithelial cells. 
Surprisingly, we found that factors released from 
the amniotic membrane circles were different from 
those released from Cell Fractions 1 and 2. One 
explanation for this observation may be that the 
relative proportion of growth factors released by the 
different cell fractions are depended on the interac-
tions between cells present in the tested cultures. 
Indeed, our cultures comprised quite different pro-
portions of the different cell types. Cell Fraction 1 
contained a high proportion of mesenchymal cells 
(86% cells with CD73+ phenotype); hAM cultures 
comprised both hAMSCs and hAECs (about 45% 
hAMSC and 55% hAEC cells); and Cell Fraction 2 
comprised mainly cells that expressed cytokeratin, 
which suggested that it comprised mainly hAECs, 
consistent with the cited procedure [6]. Moreover, 
the growth factors and receptors released by Cell 
Fraction 2 cultures were quite different from those 
released by other cultures.
An alternative explanation for the differences 
between the types and proportions of growth factors 
released between cell fractions and hAMs may be 
related to the type of culture media used. It is known 
that culture medium may affect expression of cell 
markers [27–29]. We have used serum-free RPMI 
1640 as a culture medium which should have minimal 
impact on amnion in vitro to mimic in vivo conditions.
We are aware that human amnions release many 
more active biological factors, however, in this study 
we were limited by the 41 factors of the applied pro-
tein array. 
In our experiment on HUVEC culture we ob-
served more intensive migration of HUVEC in cultu-
res with addition of 24 h hAM culture medium, than 
without the addition. Also, our experiment showed 
that IGF-2 was continually released into the culture 
media of cultured hAM over the 48 h time period. 
Bid et al. suggested role for IGF-2 in angiogenesis 
on HUVECs culture model [30]. We propose that 
the observed migratory effect on HUVEC may be 
due to the IGF-2 presence in the 24 h hAM culture 
medium or appearance of other released, however, 
not tested factors. 
In conclusion, we showed that protein-free cultu-
re media conditioned by human amnion or isolated 
amniotic cell populations contained several growth 
factors and receptors. The presence and secretion of 
several growth factors in human amnion membranes 
and amniotic cells was observed for the first time. 
It may be suggested that amnion and amniotic cells 
might be a source of valuable growth factors for re-
generative medicine. 
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